[CRVS] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
05-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -5.10%
YoY- -231.78%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,580 -12,935 -11,643 -14,301 -16,036 -6,347 -1,913 34.96%
Tax -3 0 0 0 0 0 -1 20.07%
NP -11,580 -12,935 -11,643 -14,301 -16,036 -6,347 -1,913 34.96%
Tax Rate - - - - - - - -
Total Cost 11,580 12,935 11,643 14,301 16,036 6,347 1,913 34.96%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -0.34 -0.44 -0.40 -0.63 -0.79 -5.39 -0.09 24.77%
EPS Diluted -0.34 -0.44 -0.40 -0.63 -0.79 -5.39 -0.09 24.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.